These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8429349)

  • 1. Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
    Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Fukumura T; Kawai Y; Koga H; Masuda K
    J Nucl Med; 1993 Feb; 34(2):288-90. PubMed ID: 8429349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
    el-Shirbiny AM; Yeung H; Imbriaco M; Michaeli J; Macapinlac H; Larson SM
    J Nucl Med; 1997 Aug; 38(8):1208-10. PubMed ID: 9255151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.
    Wu HC; Yen RF; Shen YY; Kao CH; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):503-6. PubMed ID: 12242515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
    Abe K; Sasaki M; Kuwabara Y; Koga H; Baba S; Hayashi K; Takahashi N; Honda H
    Ann Nucl Med; 2005 Oct; 19(7):573-9. PubMed ID: 16363622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Foo SS; Ramdave S; Berlangieri SU; Scott AM
    Australas Radiol; 2004 Jun; 48(2):214-6. PubMed ID: 15230758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
    Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
    Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
    J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm.
    Pezeshk P; Sadow CA; Winalski CS; Lang PK; Ready JE; Carrino JA
    Acad Radiol; 2006 Aug; 13(8):1011-5. PubMed ID: 16843854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
    Bury T; Barreto A; Daenen F; Barthelemy N; Ghaye B; Rigo P
    Eur J Nucl Med; 1998 Sep; 25(9):1244-7. PubMed ID: 9724372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography and bone scintigraphy of an osteoclast metastasis].
    Chapot C; al Roubaie Z; Kirsch CM
    Nuklearmedizin; 1998 Aug; 37(5):183-6. PubMed ID: 9728346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible Tc-99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. A comparative study using PET FDG whole body imaging.
    Meyer MA; McClaughry P
    Clin Nucl Med; 1995 Sep; 20(9):767-9. PubMed ID: 8521650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ; Maisey MN; Fogelman I
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma.
    Lee J; Park CH; Kim HC; Kim HS
    Clin Nucl Med; 2000 Jul; 25(7):532-5. PubMed ID: 10885695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting Enhances the Contrast of Bone Metastatic Lesions in
    Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468238
    [No Abstract]   [Full Text] [Related]  

  • 18. False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
    An YS; Yoon JK; Lee MH; Joh CW; Yoon SN
    Clin Nucl Med; 2005 Mar; 30(3):203-4. PubMed ID: 15722832
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
    Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
    Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.
    Yeh SD; Imbriaco M; Larson SM; Garza D; Zhang JJ; Kalaigian H; Finn RD; Reddy D; Horowitz SM; Goldsmith SJ; Scher HI
    Nucl Med Biol; 1996 Aug; 23(6):693-7. PubMed ID: 8940712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.